Nitazenes: The Next Wave in America’s Overdose Crisis. And Why Providers Must Act Now

by | Jan 7, 2026 | Articles, Recovering Hope Treatment Center Updates

Written By: Carmichael Finn · 10 comments

Nitazenes, an ultra-potent class of synthetic opioids up to 40 times stronger than fentanyl, are rapidly infiltrating the U.S. drug supply, often without people knowing they’re taking them. As these compounds drive a new wave of overdoses, treatment providers must act quickly: educate clients, expand harm-reduction efforts, and prepare for overdoses requiring multiple doses of naloxone.

Over the last decade, we’ve watched fentanyl reshape the landscape of substance use in America. Overdoses changed. Risk patterns changed. Treatment changed. And now, something even more potent is entering the supply—quietly and quickly.

Need help for yourself or someone you love?

Call 844-314-HOPE or email referrals@recoveringhope.life

What Are Nitazenes?

Nitazenes (benzimidazole-opioids) are a class of synthetic opioids first developed by a Swiss pharmaceutical company in the late 1950s but never approved for medical use in the United States. After decades of near invisibility, they began reappearing in illicit drug markets around 2019.
Clients aren’t asking for nitazenes. They’re falling into them.

How Potent Are Nitazenes?

Nitazenes range from slightly less potent than fentanyl to more than 40 times stronger, with some analogs reaching thousands of times the potency of morphine.
    • Fentanyl: 25–50× stronger than heroin
    • Some nitazenes: 5–9× stronger than fentanyl
    • Others: up to 25–43× stronger
A person can overdose on an amount they cannot see, taste, or detect. That’s the danger.

Why Are Nitazenes Showing Up in the Drug Supply?

    • Mixed with fentanyl
    • Sold as heroin
    • Hidden in counterfeit pain pills
    • Laced into benzodiazepine-like pills
    • Blended into powders to cheaply increase potency
People don’t know what they’re taking. That is the crisis.

What Providers Must Do Now

    1. Educate clients immediately using non-shaming harm-reduction language
    1. Encourage multiple naloxone kits
    1. Normalize conversations about supply unpredictability
    1. Integrate nitazene education into groups and sessions
    1. Train staff on rapid overdose recognition and response

Awareness is prevention. Education is prevention. Compassion is prevention.

Call 844-314-HOPE • Email referrals@recoveringhope.life

About the Author

Carmichael McKinley Finn, MA, LMFT, LADC, ADCR-MN is an Executive Director, clinician, educator, and national presenter specializing in substance use disorder (SUD) treatment, trauma, and behavioral health leadership. He leads Recovering Hope Treatment Center in Mora, Minnesota—a women- and family-centered program providing residential and outpatient services—and teaches in collegiate behavioral health programs across Minnesota.

Quitting Smoking Improves Addiction Recovery by 42%—So Why Aren’t We Acting?

Quitting smoking during addiction treatment isn’t just good for your health—it can dramatically improve your chances of staying in recovery.
A 2024 NIH-funded study found that people who quit smoking had 42% greater odds of maintaining recovery from alcohol or other drug use compared to those who continued smoking. This isn’t an isolated finding—decades of research show that smoking increases relapse risk, worsens mental health, and lowers quality of life for people in treatment.

Monthly Fatal Drug Overdose Snapshot: January 2026

The Minnesota Department of Health (MDH) recently introduced a Monthly Fatal Drug Overdose Snapshot, a new tool designed to provide near real-time information on overdose deaths across Minnesota. The January 2026 snapshot offers a clearer, more immediate look at trends so communities, providers, and policymakers can respond faster to the ongoing overdose crisis.

What Makes a Family-Centered Treatment Model Work?

At Recovering Hope Treatment Center, family-centered care isn’t a tagline—it’s a lived experience. From onsite trauma-informed daycare to coordinated prenatal care and walking trails where moms and children can reconnect, every part of our model is designed to support healing without separation. Because when a mother heals, a family begins to thrive.

What 540,000 Participants Teach Us About Spirituality and Substance Use

Emerging research is challenging the assumption that cannabis supports long-term trauma recovery. A recent 12-week study in the Journal of Clinical Psychiatry found that individuals with both PTSD and cannabis use disorder who achieved sustained abstinence experienced significantly greater reductions in PTSD symptoms than those who continued using. While preliminary, the findings suggest that ongoing cannabis use may slow improvement in key areas like avoidance, negative mood, and hyperarousal. In early recovery, sharing data like this isn’t about coercion—it’s about informed consent, clinical transparency, and helping clients make decisions grounded in evidence rather than assumption.

Leading Through Tragedy: What Clinical Supervisors Owe Their Staff When the World Is Loud and Grieving

When public tragedy happens, it does not stay outside the therapy room. In this piece, Carmichael Finn explores what clinical supervisors owe their staff during moments of collective grief—offering practical, ethical guidance for leading with steadiness when both clinicians and clients are impacted at the same time.

Cannabis, PTSD, and Early Recovery: Why Clients Deserve to See the Data

Emerging research is challenging the assumption that cannabis supports long-term trauma recovery. A recent 12-week study in the Journal of Clinical Psychiatry found that individuals with both PTSD and cannabis use disorder who achieved sustained abstinence experienced significantly greater reductions in PTSD symptoms than those who continued using. While preliminary, the findings suggest that ongoing cannabis use may slow improvement in key areas like avoidance, negative mood, and hyperarousal. In early recovery, sharing data like this isn’t about coercion—it’s about informed consent, clinical transparency, and helping clients make decisions grounded in evidence rather than assumption.

The Maternal Mortality Crisis Obstetrics Is Not Built to Solve

Vaping around babies and children isn’t harmless. In this article, Sadie Broekemeier, MA, LADC, LPCC, explains how secondhand and thirdhand vape exposure can affect children’s health, why developing lungs and brains are especially vulnerable, and what caregivers can do to reduce risk and keep kids safe.By Carmichael Finn, MA, LMFT, LADC, AADCR-MN | Recovering Hope Executive Director

Fraud Must Be Prosecuted. Clients Must Be Protected. What Minnesota’s Medicaid Crisis Is Teaching Us About System Failure

Vaping around babies and children isn’t harmless. In this article, Sadie Broekemeier, MA, LADC, LPCC, explains how secondhand and thirdhand vape exposure can affect children’s health, why developing lungs and brains are especially vulnerable, and what caregivers can do to reduce risk and keep kids safe.By Carmichael Finn, MA, LMFT, LADC, AADCR-MN | Recovering Hope Executive Director

Why Vaping Around Babies and Children Is More Dangerous Than Many Parents Realize

Vaping around babies and children isn’t harmless. In this article, Sadie Broekemeier, MA, LADC, LPCC, explains how secondhand and thirdhand vape exposure can affect children’s health, why developing lungs and brains are especially vulnerable, and what caregivers can do to reduce risk and keep kids safe.By Carmichael Finn, MA, LMFT, LADC, AADCR-MN | Recovering Hope Executive Director

I read the study so you don’t have to: what this AUD “endocannabinoid gene rewiring” paper actually means for clinical practice

Decades of alcohol use don’t just form habits—they reshape the brain systems that regulate reward, impulse control, and stress. This article translates a complex neuroscience study on alcohol use disorder and the endocannabinoid system into practical, clinician-friendly insight, explaining why motivation alone often fails, why relapse risk rises under stress, and why structure matters more than willpower early in recovery.
By Carmichael Finn, MA, LMFT, LADC, AADCR-MN | Recovering Hope Executive Director